» Articles » PMID: 30443766

Risk of Venous Thromboembolism After Endoprosthetic Surgeries: Lower Versus Upper Extremity Endoprosthetic Surgeries

Overview
Journal Heart Vessels
Date 2018 Nov 17
PMID 30443766
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Venous thromboembolism (VTE) is a potentially fatal disease. Important risk factors of a provoked VTE are trauma, surgery or immobilization. Especially, patients who undergo hip and knee replacements are at high risk for postoperative VTE. We aimed to compare in-hospital VTE burden and other outcomes after upper and lower extremity endoprosthetic surgeries in Germany. The nationwide German inpatient sample of the years 2005-2015 was used for data analysis. Patients who underwent endoprosthetic joint/bone replacements of the extremities (OPS codes 5-820, 5-822, 5-824 and 5-826) were further stratified in those operated on lower (OPS codes 5-820, 5-822 and 5-826) or upper extremity (OPS code 5-824) joints. Patients operated at upper and lower extremity were compared and lower extremity endoprosthetic surgery was investigated as a predictor for adverse outcomes. Overall, 4,134,088 hospitalized patients with extremity joint endoprosthetic surgeries (64.3% females, 54.0% aged > 70 years) were included in our analysis. Of these, 3,950,668 patients (95.6%) undergo lower and 183,420 (4.4%) upper extremity endoprosthetic joint surgery. VTE [RR 2.60 (95% CI 2.41-2.79), P < 0.001] and all-cause death [RR 1.68 (95% CI 1.58-1.77), P < 0.001] were more common in patients with lower extremity joint surgery. Risk for VTE events [OR 2.69 (2.50-2.90), P < 0.001] and in-hospital death [OR 1.65 (1.56-1.75), P < 0.001] were both higher in lower than in upper extremity joint surgeries independently of age, sex and comorbidities. Patients who undergo lower extremity endoprosthetic joint surgeries, bear a higher risk for VTE and in-hospital death compared to those with upper extremity endoprosthetic joint surgeries.

Citing Articles

Venous thromboembolism in patients hospitalized for knee joint replacement surgery.

Keller K, Hobohm L, Barco S, Schmidtmann I, Munzel T, Engelhardt M Sci Rep. 2021; 10(1):22440.

PMID: 33384429 PMC: 7775461. DOI: 10.1038/s41598-020-79490-w.


Venous thromboembolism prophylaxis in patients undergoing knee replacements: comparison of real-world outcomes.

Hasan S, Sunter W, Ahmed N, Dawoud D, Zaidi S Int J Clin Pharm. 2020; 43(3):621-628.

PMID: 33070296 PMC: 8214589. DOI: 10.1007/s11096-020-01173-3.

References
1.
Stringer M, Steadman C, Hedges A, Thomas E, Morley T, Kakkar V . Deep vein thrombosis after elective knee surgery. An incidence study in 312 patients. J Bone Joint Surg Br. 1989; 71(3):492-7. DOI: 10.1302/0301-620X.71B3.2785998. View

2.
Lu Y, Zhou Z, Liu Y, Chen H, Yang H, Liu F . Gender differences of venous thromboembolism risk after total hip and total knee arthroplasty: a meta-analysis. J Thromb Thrombolysis. 2015; 41(4):556-62. DOI: 10.1007/s11239-015-1283-6. View

3.
Silverstein M, Heit J, Mohr D, Petterson T, OFallon W, Melton 3rd L . Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998; 158(6):585-93. DOI: 10.1001/archinte.158.6.585. View

4.
Evarts C, Feil E . Prevention of thromboembolic disease after elective surgery of the hip. J Bone Joint Surg Am. 1971; 53(7):1271-80. View

5.
Liddle A, Judge A, Pandit H, Murray D . Adverse outcomes after total and unicompartmental knee replacement in 101,330 matched patients: a study of data from the National Joint Registry for England and Wales. Lancet. 2014; 384(9952):1437-45. DOI: 10.1016/S0140-6736(14)60419-0. View